Welcome to the Ritlecitinib Showcase. This page includes information related to ritlecitinib, a kinase inhibitor, approved for the treatment of alopecia areata (AA) in patients ≥12 years of age. This showcase presents a collection of published manuscripts, plain language summaries, video abstracts, digital infographics and congress posters.
